CRO Medicus Research Named Winner of NBJ Science Achievement Award
NBJ's highly anticipated Awards Issue has announced the natural products industry's most notable business leaders of 2013. Global CRO Medicus Research was named winner of the prestigious Science Award for its work with natural health products.
- (1888PressRelease) January 22, 2014 - Los Angeles, CA - Medicus Research is the recipient of the prominent Nutrition Business Journal (NBJ) 2013 Industry Achievement Award for Science.
The USA-based global contract research organization, which specializes in the natural health products industry, receives the award for raising the bar for science in supplements by designing pharmaceutical-level clinical trials that make sense and are well suited for the unique demands of the natural products industry.
In announcing this year's winners in various categories, the journal stated that the NBJ Awards reflect the best in an industry, with the winning companies committed to growing a market of healthy, educated consumers and fostering a business environment that encourages sustainability.
"We take great pride in spotlighting those individuals and organizations working to advance the cause of the industry," said NBJ Editor in Chief Marc Brush. "We received close to 300 nominations this year. After careful vetting by our editorial staff and our advisory board, Dr. Udani's efforts rose to the top."
Dr. Udani's vision a decade-and-a-half ago of the future of the natural health products industry, his mission to address the challenges, and his determination to mainstream The Udani Theory of Natural Health Product Clinical Trial Design was the basis for his nomination.
"We are truly honored by this esteemed recognition," said Medicus Research founder/CEO, Dr. Jay Udani. "Receiving the NBJ Science Award is further evidence of Medicus Research's leadership and innovation as the global CRO specializing in the natural health products industry."
In 2013 alone, Medicus Research conducted 70 research studies, had an impressive eight studies published in peer-reviewed journals, and was granted two patents. With federal regulators, lawmakers and the media increasingly questioning the efficacy and safety of dietary supplements, Medicus Research is prepared for a very active 2014.
"The industry is often characterized in the media as non-scientific," said Dr. Udani. "The problem is that the people who are investing in the research are doing it wrong," he says. "If you run a study for dietary supplements in the same way as a pharmaceutical study, you are less likely to see positive results."
As the premier publication for the nutrition, natural, organic, dietary supplement and integrative medicine industries, NBJ recognizes the industry's most noteworthy leaders through its highly anticipated annual business achievement awards, dedicated to recognizing individuals and companies who are committed to advancing the audience of healthy, educated consumers and fostering a business atmosphere that encourages sustainability and better nutrition.
Recipients of the NBJ Awards will be honored during the 17th annual NBJ Summit, July 22-25, 2014 at the St. Regis Hotel Monarch Beach Resort in Dana Point, CA.
To view the entire list of winners, go to: http://newhope360.com/business/winners-2013-nbj-awards.
Medicus Research
Medicus Research is an internationally renowned contract research organization specializing in the study of dietary supplements, functional foods, medical foods, botanical drugs and cosmeceuticals. The California-based CRO was founded by Jay Udani, MD, who is recognized as a Key Opinion Leader in the global natural health products industries. Dr. Udani was recently honored by PharmaVOICE magazine as one of the 100 Most Inspiring People in the Life-Sciences Industry.
Medicus Research has designed, executed and analyzed more than 150 Phase I - IV clinical trials. The company designs its clinical trials to guarantee that its studies are structure/function compliant and follow strict guidelines issued by FTC, FDA, and EFSA for subject population and endpoint selection. Medicus Research has established GCP and FDA compliant SOPs, internal QA processes, and proprietary management technology systems which ensure the highest quality for all aspects of the study process.
In 2013, Medicus Research conducted 70 research studies, successfully defended claims with FTC,FDA, NAD and class action lawsuits, had an impressive eight studies published in peer reviewed journals, won top awards for two scientific abstracts, published results for the first virtual clinical trial for Natural Health products, and was granted two patents.
Learn more about Medicus Research by visiting www.MedicusResearch.com.
Contact Medicus Research:
Matt Mathelin
Mathieu.mathelin ( @ ) medicusresearch dot com
818-404-8330
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam